Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Collegium Pharma
(NQ:
COLL
)
38.61
+1.52 (+4.10%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 29, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
509,530
Open
37.21
Bid (Size)
38.00 (1)
Ask (Size)
39.50 (11)
Prev. Close
37.09
Today's Range
37.00 - 38.92
52wk Range
20.95 - 40.95
Shares Outstanding
32,213,751
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024
August 28, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Organon Stock Sees Relative Strength Rating Rise To 91
August 27, 2024
On Tuesday, Organon[ stock hit an key technical milestone, seeing its Relative Strength Rating jump to 91, up from 88 the day before.
Via
Investor's Business Daily
Performance
YTD
+23.63%
+23.63%
1 Month
+0.03%
+0.03%
3 Month
+19.06%
+19.06%
6 Month
+5.18%
+5.18%
1 Year
+63.74%
+63.74%
More News
Read More
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
Via
Investor's Business Daily
The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts
August 09, 2024
Via
Benzinga
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
May 10, 2024
Via
Benzinga
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
April 11, 2024
Via
Benzinga
Collegium Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
In a market where value is scarce, NASDAQ:COLL offers a refreshing opportunity with its solid fundamentals.
August 06, 2024
Via
Chartmill
Collegium to Acquire Ironshore Therapeutics, Expanding into Neurology
July 29, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
July 25, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
NASDAQ:COLL is an undervalued gem with solid fundamentals.
July 16, 2024
Via
Chartmill
Dr. Reddy's Labs Stock Sees Improved Technical Strength
June 28, 2024
Via
Investor's Business Daily
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
Via
InvestorPlace
NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals.
June 24, 2024
Via
Chartmill
Collegium Obtains Six Month Extension of U.S. Pediatric Exclusivity for Nucynta Franchise
June 13, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in Jefferies Global Healthcare Conference
May 29, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces $35 Million Accelerated Share Repurchase Program
May 13, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Collegium Reports First Quarter 2024 Financial Results
May 09, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces CEO Transition
May 09, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Announces Authorized Generic Agreement with Hikma Pharmaceuticals USA Inc. for Nucynta® and Nucynta® ER
April 29, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
April 25, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
April 11, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
April 03, 2024
From
Collegium Pharmaceutical, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.